Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... International Federation of Gynecology and Obstetrics (FIGO) stage IIIC and IV primary epithelialovarian, fallopian tube, or peritoneal cancer; the frequency of use of different ...
2009 NOV 16 ... carcinomas by immunohistochemistry and correlated ER-beta expression with markers of epithelial-mesenchymal transition (EMT). ER-beta was expressed in 83% of tumour specimens where it ... the pathological processes of hormone-dependent cancers, such as breast, prostate and ovarian cancers, through its receptors, estrogen receptor-alpha (ER-alpha) and -beta ... into an invasive state. However, it is unclear whether ER-beta plays a role in laryngeal cancer. In the present study we examined the expression of ER-beta in 80 invasive human ...
2009 NOV 23 ... island." "The molecular mechanisms involved in RUNX3 gene expression and epithelial ovarian cancer are not fully understood. This study investigates the relationship between RUNX3 ...
2009 NOV 23 ... been presented. According to recent research published in the journal Neoplasia, "The epithelial-to-mesenchymal transition (EMT) that occurs during embryonic development is ... epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovariancancer cells' have been presented. According to recent research published in the ...
2009 NOV 9 ... "Here we investigated whether AM expression could be induced by bFGF in human ovarianepithelial carcinoma cells and explored the mediating mechanism. The expression of AM was examined ... Republic of China, Shenyang, Critical Care Medicine, Enzyme Research, Epithelial Cancer, Epithelial Carcinoma, Kinase, Oncology. This article was prepared by ...
2009 NOV 23 ... spectrometry. Each cell line represented one of the major histological types of epithelial ovarian cancer. We identified 2039 proteins from which 228 were extracellular and 192 were plasma ...
2009 NOV 23 ... weekly regimen in women with advanced ovarian cancer. Patients with stage II to IV epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer were eligible for enrolment in this ...
2009 NOV 16 ... age; they represent 70% of ovarian tumors in this age group.(1) Unlike the more common epithelialovarian tumors, ovarian GCTs grow rapidly, yet most patients present with stage IA ... USA. Keywords: United States, Cleveland, Endodermal Sinus Tumors, Chorio Cancer, Chorio Carcinoma, Dysgerminoma, Embryonal Cancer, Endodermal Sinus Tumor, Germ Cell ...
2009 NOV 23 ... long-term results of fertility-sparing surgery in the treatment of early-stage invasive epithelial ovarian cancer. A retrospective review of 123 patients who underwent surgical staging for FIGO stage I ...
2009 NOV 9 ... we investigated the aberrant expression of human sperm protein 17 (HSp17) in human epithelial ovarian cancer cells and tried to analyze its influences on the cell behaviors like migration and ...
2009 NOV 9 ... from Kuopio, Finland, "Transcription factor Snail1 has a central role in induction of epithelial-mesenchymal transition (EMT). The aim of the present study was to elucidate the ... of the present study was to elucidate the expression of Snail1 protein during epithelial ovarian tumourigenesis and to study the association of Snail1 expression with ... in stromal cells." Tuhkanen and colleagues published their study in BMC Cancer (Nuclear expression of Snail1 in borderline and malignant epithelial ovarian tumours is ...
2009 NOV 9 ... courses of paclitaxel are effective as consolidation treatment in patients with advanced epithelial ovarian cancer who are in complete response after first-line paclitaxel/platinum-based chemotherapy. ...
2009 NOV 16 ... and ifosfamide (ETI) in the management of heavily pretreated recurrent or persistent epithelial ovarian cancer (EOC). with recurrent or persistent EOC who had measurable disease and at least two ...
2009 NOV 9 ... (progression-free survival, PFS < 6 months) and survival in patients with epithelial ovarian cancer (EOC) who received taxane- and platinum-based chemotherapy after surgery. Between ...
2009 NOV 16 ... present study aimed to investigate GnT-V expression and its prognostic significance in epithelial ovarian cancer," scientists writing in the journal Oncology Reports report. "GnT-V ...
2009 NOV 16 ... previously that HOXA4 expression is increased in invasive, compared to noninvasive, epithelialovarian tumors. However, HOXA4 suppressed cell migration suggesting that elevated HOXA4 ... and differentiation. Increasing evidence suggests that HOX genes play a role in ovarian cancer progression; however few studies have defined functional roles and mechanisms of ...
2009 NOV 23 ... modulates ovariancancer cells invasion and is expressed in normal ovary and ovarianepithelialcancer cells; however, the upstream regulator(s) of GnRH-II expression in these cells ...
2009 NOV 16 ... more sensitive to C-CPE-PSIF than TJ-developed cells. It is noteworthy that polarized epithelial cells are sensitive to C-CPE-PSIF applied to the basal side, whereas the cells were less ... "Claudin-4 is deregulated in various cancers, including breast, prostate, ovarian, and gastric cancer. Claudin-4 may be a promising target molecule for tumor therapy, but ...
2009 NOV 23 ... long-term survival) with a strength that is better than any other prognostic factor in epithelial ovarian cancer including FIGO stage," wrote K.M. Jochumsen and colleagues, Odense University. ...
2009 NOV 16 ... G1 and cyclin B1 in ovarian tumorigenesis. We examined cyclin B1 and G1 expression in 58 epithelial ovarian cancer, 18 low-malignant-potential ovarian tumors, and 6 normal ovarian epithelium samples ...
